Happy Wednesday. It’s Sept. 4, 2025. These are today’s top moving stocks, a segment of our daily live blog, Stock Market Today.
Stocks are higher today on excitement around tomorrow’s payrolls report from the Bureau of Labor Statistics. But to find stocks making real big moves, you’ll have to zoom out from those singular figures. Here are a few making headlines today:
American Eagle
Fashion brand American Eagle AEO (+35.4%) is having itself a day. Tariff FUD and worries about a marketing controversy dominated the retailer for most of the year, but none of that can be found in its latest earnings report. It’s soaring today, with volume 10x higher than you’d see on an average day.
Related: American Eagle stock surges 35% on celebrity collabs, earnings
Figma
Figma (FIG) (-19%) might be your UI/UX designer’s favorite software tool, but it sure isn’t investors’ favorite new IPO. The company is sinking after reporting its first earnings as a publicly-traded firm, having just gone public at the end of July. The comedown might be an overreaction from speculative investors, which have pumped the market newcomer in recent days, as its results should have inspired. Revenues grew 41%, while guidance for the coming quarter outlined a vision for 33% growth.
T. Rowe Price
T. Rowe Price (TROW) (+6%) is the S&P 500’s top-performing stock today, ascending on news of a new partnership with investment bank Goldman Sachs (GS) (+2.4%). The banking goliath said that the two firms would work together to offer new investment funds with private market exposure. As part of the deal, Goldman will invest $1 billion in the bank as part of the partnership, giving it a slim ~3.5% stake in the business.
Amazon
Amazon (AMZN) (+4%) finally has a buyer for its new satellite internet service, Project Kuiper, which has become a large internal venture at the company. The Nasdaq-100’s top-performing component is rising on reports that airline JetBlue (JBLU) has signed a commitment to use the company for its free in-flight Wi-Fi starting in 2027, replacing Viasat (VSAT) (+1.1%). It’s the “first airline” to implement the Kuiper satellite tech.
Sanofi
French pharmaceutical giant Sanofi (SNY) (-9.6%) has indicated that it’s willing to spend billions to beef up its pipeline of drugs, preparing life after blockbuster asthma and COPD drug Dupixent. However, its lack of luck in the clinic has been something to study. In recent weeks, a drug prospect for COPD failed a key study. And now, it’s facing another setback in the lab. The company’s new eczema drug, amlitelimab, is sinking the company’s shares today, as results from the phase 3 trial came up short of analyst expectations.